These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27919913)

  • 1. When the price is right: drug costing and NICE approval.
    Hawkes N
    BMJ; 2016 Dec; 355():i6519. PubMed ID: 27919913
    [No Abstract]   [Full Text] [Related]  

  • 2. New NICE criteria for drug access.
    Fricker J
    Lancet Oncol; 2017 May; 18(5):576. PubMed ID: 28343973
    [No Abstract]   [Full Text] [Related]  

  • 3. New Cancer Drugs Fund is flawed without NICE reform, says Roche.
    Hawkes N
    BMJ; 2016 Jul; 354():i4216. PubMed ID: 27473207
    [No Abstract]   [Full Text] [Related]  

  • 4. NICE, the NHS, and Cancer Drugs.
    Dillon A; Landells LJ
    JAMA; 2018 Feb; 319(8):767-768. PubMed ID: 29387883
    [No Abstract]   [Full Text] [Related]  

  • 5. Being NICE is not the problem!
    Jonsson B
    Eur J Cancer; 2009 May; 45(7):1100-1102. PubMed ID: 19268570
    [No Abstract]   [Full Text] [Related]  

  • 6. Pfizer makes breast cancer drug free while NICE decides its future.
    Kmietowicz Z
    BMJ; 2017 May; 357():j2225. PubMed ID: 28483771
    [No Abstract]   [Full Text] [Related]  

  • 7. Expensive cancer therapies: unintended effects.
    Delude CM
    J Natl Cancer Inst; 2015 Jan; 107(1):497. PubMed ID: 25564602
    [No Abstract]   [Full Text] [Related]  

  • 8. A new anti-cancer drug in the market: Good news for investors or for patients?
    Apolone G; Tafuri G; Trotta F; Garattini S
    Eur J Cancer; 2008 Sep; 44(13):1786-8. PubMed ID: 18672359
    [No Abstract]   [Full Text] [Related]  

  • 9. The high price of progress.
    Nat Rev Clin Oncol; 2017 Feb; 14(3):129. PubMed ID: 28218258
    [No Abstract]   [Full Text] [Related]  

  • 10. NICE approval of new hepatitis drug could result in £700m bill for NHS.
    Hawkes N
    BMJ; 2015 Oct; 351():h5554. PubMed ID: 26491096
    [No Abstract]   [Full Text] [Related]  

  • 11. NICE and the challenge of cancer drugs.
    Raftery J
    BMJ; 2009 Jan; 338():b67. PubMed ID: 19141502
    [No Abstract]   [Full Text] [Related]  

  • 12. Bad month for cancer care in the UK.
    Lancet Oncol; 2010 Aug; 11(8):701. PubMed ID: 20688267
    [No Abstract]   [Full Text] [Related]  

  • 13. NICE proposes faster process to appraise cheaper drugs.
    Mayor S
    BMJ; 2016 Oct; 355():i5592. PubMed ID: 27797748
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel schemes skirt NICE barrier.
    Elvidge S
    Nat Biotechnol; 2011 Aug; 29(8):677. PubMed ID: 21822231
    [No Abstract]   [Full Text] [Related]  

  • 15. Price, value, and the cost of cancer drugs.
    Fojo T; Lo AW
    Lancet Oncol; 2016 Jan; 17(1):3-5. PubMed ID: 26758749
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer Drugs Fund 2.0: A Missed Opportunity?
    McCabe C; Paul A; Fell G; Paulden M
    Pharmacoeconomics; 2016 Jul; 34(7):629-33. PubMed ID: 27002519
    [No Abstract]   [Full Text] [Related]  

  • 17. Novartis's Kymriah: Harnessing Immune System Comes With Worry About Reining in Costs.
    Morrow T
    Manag Care; 2017 Oct; 26(10):28-30. PubMed ID: 29068298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indian drug maker cuts price of three cancer drugs by between 50% and 63%.
    Kay M
    BMJ; 2012 Nov; 345():e7786. PubMed ID: 23160905
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer drugs fund receives boost but will no longer fund "overpriced" drugs.
    Hawkes N
    BMJ; 2014 Sep; 349():g5382. PubMed ID: 25180006
    [No Abstract]   [Full Text] [Related]  

  • 20. NICE says drug for metastatic breast cancer is unaffordable for NHS.
    Kmietowicz Z
    BMJ; 2014 Apr; 348():g2888. PubMed ID: 24759923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.